GT Biopharma, Inc. (GTBP)

0.47 +0.02 (+3.41%) USD  |  NASDAQ  |  Mar 05, 16:00
0.4589 -0.01 (-2.36%) After-Hours: 20:00
More

GT Biopharma Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
Geron Corp. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade